MedTrace Logo

Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy

NCT00409227 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2008-06-18

No results posted yet for this study

Summary

In latest literature more evidence is available about the positive effect of alpha blocker on stone expulsion from the ureter. Patients benefit from less pain and shortening time to stone expulsion. Our study is design to evaluate whether alfuzosin improves the stone free out come following SWL.

Conditions

  • Urolithiasis
  • Nephrolithiasis
  • Ureterolithiasis

Interventions

DRUG

Alpha blocker-alfuzosin

P.O. alfuzosin 10 mg once a day

DRUG

placebo

placebo once a day for 3 months or stone free

Sponsors & Collaborators

  • Assaf-Harofeh Medical Center

    lead OTHER_GOV

Principal Investigators

  • yoram I siegel, MD · Endourology unit Urology department Assaf harofeh MC.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2009-07-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00409227 on ClinicalTrials.gov